Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.
2.

Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics.

Novak E, Allen PJ.

Pediatr Nurs. 2007 Jan-Feb;33(1):64-70. Review.

PMID:
17411005
3.

The march toward rational therapeutics in children.

Gorman RL.

Pediatr Infect Dis J. 2003 Dec;22(12):1119-23. Review.

PMID:
14688584
4.

[How to improve drug development and utilization in pediatrics].

Pons G, Lassale C, Eschwege E.

Therapie. 1999 Jul Aug;54(4):423-32. Review. French.

PMID:
10667109
5.

IOM Review of FDA--approved biologics labeled or studied for pediatric use.

Field MJ, Ellinger LK, Boat TF.

Pediatrics. 2013 Feb;131(2):328-35. doi: 10.1542/peds.2012-2412. Epub 2013 Jan 14. Review.

6.

Pediatric use of topical ophthalmic drugs.

Coulter RA.

Optometry. 2004 Jul;75(7):419-29. Review.

PMID:
15296375
7.

Regulatory issues in pediatric psychopharmacology.

Laughren TP.

J Am Acad Child Adolesc Psychiatry. 1996 Oct;35(10):1276-82. Review.

PMID:
8885581
8.

Criteria supporting the study of drugs in the newborn.

Ward RM, Benitz WE, Benjamin DK Jr, Blackmon L, Giacoia GP, Hudak M, Lasky T, Rodriguez W, Selen A.

Clin Ther. 2006 Sep;28(9):1385-98. Review.

PMID:
17062311
9.
10.

[Medicines for children: time to act!].

Saint-Raymond A, Brasseur D, Seigneuret N.

Arch Pediatr. 2005 Aug;12(8):1195-8. Review. French. No abstract available.

PMID:
15913970
11.

The economics of pediatric formulation development for off-patent drugs.

Milne CP, Bruss JB.

Clin Ther. 2008 Nov;30(11):2133-45. doi: 10.1016/j.clinthera.2008.11.019. Review.

PMID:
19108801
13.

Pediatric exclusivity: evolving legislation and novel complexities within pediatric therapeutic development.

Rivera DR, Hartzema AG.

Ann Pharmacother. 2014 Mar;48(3):369-79. doi: 10.1177/1060028013514031. Epub 2013 Dec 5. Review.

PMID:
24311725
14.

Advances in pediatric pharmacology, therapeutics, and toxicology.

Berlin CM Jr.

Adv Pediatr. 2001;48:439-64. Review.

PMID:
11480767
15.

The evolution of legislation to regulate pediatric clinical trials: Present and continuing challenges.

Gans-Brangs KR, Plourde PV.

Adv Drug Deliv Rev. 2006 Apr 20;58(1):106-15. Epub 2006 Mar 10. Review.

PMID:
16530291
16.

Realizing the promise of the US Food and Drug Administration Modernization Act.

Wolgemuth RL.

Clin Ther. 1998;20 Suppl C:C26-31. Review.

PMID:
9915087
17.

Paediatric labelling requirements. Implications for pharmacokinetic studies.

Wilson JT, Kearns GL, Murphy D, Yaffe SJ.

Clin Pharmacokinet. 1994 Apr;26(4):308-25. Review.

PMID:
8013163
18.

Paediatric clinical trials: redressing the imbalance.

Schreiner MS.

Nat Rev Drug Discov. 2003 Dec;2(12):949-61. Review. No abstract available.

PMID:
14654794
19.

The industrialization of clinical research.

Rettig RA.

Health Aff (Millwood). 2000 Mar-Apr;19(2):129-46. Review.

20.

Challenges in conducting pediatric drug trials.

Berlin CM Jr.

J Allergy Clin Immunol. 2000 Sep;106(3 Suppl):S125-7. Review.

PMID:
10984392
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk